Recom Bio is a wholly owned subsidiary of Yili Chuanning Biotech Co., Ltd. (301301.SZ) under Kelun Pharma Group (002422.SZ), is a high-end R&D and Innovation Center for Chuanning biosynthetic bio manufacturing. Recom Bio employs cutting-edge synthetic biology technologies, supplemented by automated and intelligent high-throughput biological casting equipment, to conduct research and development of high-value-added products. The products are mainly focused on high value-added biomedical active ingredients, natural preservative raw materials and other sectors. A number of efficient chassis bacteria and enzyme libraries with millions of independent intellectual property rights have been developed. The core R&D personnel come from well-known R & D institutions at home and abroad and have many years of work experience in the synthetic biology industry.

We adhere to the concept of "Reconstructing cell factories to create a green future", through independent innovation and external cooperation, we break the internal competition and integrate with peers to share and utilize the high-quality industrial ecological resources of the group. At the same time, we build a synthetic biology CDMO industry platform, enabling the company to grow into a leading synthetic biology enterprise with a global professional perspective and industry competitiveness.